Correlation Between Cannara Biotech and Choom Holdings

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and Choom Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and Choom Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cannara Biotech and Choom Holdings, you can compare the effects of market volatilities on Cannara Biotech and Choom Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of Choom Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and Choom Holdings.

Diversification Opportunities for Cannara Biotech and Choom Holdings

0.54
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cannara and Choom is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and Choom Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Choom Holdings and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with Choom Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Choom Holdings has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and Choom Holdings go up and down completely randomly.

Pair Corralation between Cannara Biotech and Choom Holdings

If you would invest  51.00  in Cannara Biotech on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Cannara Biotech or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.65%
ValuesDaily Returns

Cannara Biotech  vs.  Choom Holdings

 Performance 
       Timeline  
Cannara Biotech 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Cannara Biotech may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Choom Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Choom Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Cannara Biotech and Choom Holdings Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cannara Biotech and Choom Holdings

The main advantage of trading using opposite Cannara Biotech and Choom Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, Choom Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Choom Holdings will offset losses from the drop in Choom Holdings' long position.
The idea behind Cannara Biotech and Choom Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world